Evidence map›Paper›PMID 41366019›Full record

ArticleScientific reports2025

METTL3-mediated m

Xi Wang, Yi Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xi WangThe Second Hospital of Tianjin Medical University, No.23, Pingjing Road, Hexi District, Tianjin, 300211, People's Republic of China. wangxi202@tmu.edu.cn.
Yi LiThe Second Hospital of Tianjin Medical University, No.23, Pingjing Road, Hexi District, Tianjin, 300211, People's Republic of China.

Funding

Tianjin Municipal Science and Technology Committee, China No. 2024KJ195
6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is a major global health concern with a 5-year survival rate of approximately 50%, driven by high recurrence and metastasis. N

Indexed as

AdenosineCarcinoma, Squamous CellForkhead Transcription FactorsHeterogeneous-Nuclear Ribonucleoprotein Group A-BMethyltransferasesMouth NeoplasmsAnimalsCell Line, TumorCell MovementCell ProliferationDisease ProgressionEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansMaleAdenosineForkhead Transcription FactorsFOXQ1 protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group A-BMethyltransferasesMETTL3 protein, humanN-methyladenosineFOXQ1HNRNPA2B1m6AMETTL3Oral squamous cell carcinoma

Identifiers

PMID41366019
PMCPMC12815929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.